account_circle info brightness_medium left_panel_close view_agenda grid_view

expand_moreexpand_less

Bosnia & Herzegovina

World

favorites

archive

We use cookies to provide some features and experiences in QOSHE

More information . Close

In drug trials, lack of oversight of research ethics boards could put Canadian patients at risk

In drug trials, lack of oversight of research ethics boards could put Canadian patients at risk

Canada has no accreditation or inspection system for research ethics boards for clinical drug trials, and no oversight mechanism for the way that they...

Joel Lexchin

Canada’s new drug pricing guidelines are industry friendly

The Patented Medicine Prices Review Board’s mandate is to make sure that drug prices are not excessive. However, new guidelines that change criteria...

24.07.2025 10

Joel Lexchin

How Donald Trump’s tariffs threaten Canadians’ access to prescription drugs

U.S. tariffs present not only a risk of Canadian job losses — and loss of access to employer-sponsored drug plans — but also the risk of higher...

04.05.2025 10

Joel Lexchin

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their...

Joel Lexchin